Treatment of established tumor is associated with ICAM-1 upregulation and reversed by CD8 depletion in a tumor necrosis factor-alpha gene transfected mouse mammary tumor

Pathobiology

Volumn 67, Issue 4, 1999, Pages 186-195

  Matory, Yvedt L ^a   Dorfman, David M ^a   Wu, Lei ^a   Chen, Man ^a   Goedegebuure, Peter ^a,b   Eberlein, Timothy J ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

ICAM 1; Mouse mammary tumor; TNF

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR VOLUME;

ANIMALIA;

EID: 0343415551     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028071     Document Type: Article

References (47)

1. Arca M, Krauss J, Aruga A, Cameron M, Chang A: Concurrent induction of CD4+ and CD8+ T cells during tumor growth with antitumor reactivity in adoptive immunotherapy. J Immunother 1997;20:138.
2. Blankenstein T, Qin Z, Oberla K, Muller W, Rosen H, Volk HD, Dimanstein T: Tumor suppression after tumor cell-targeted tumor necrosis factor a gene transfer. J Exp Med 1991;173: 1047.
3. Rink L, Kirchner H: Recent progress in the tumor necrosis factor-alpha field. Int Arch Allergy Immunol 1996;111:199-209.
4. Donahue R, Kessler S, Bodine D, McDonagh K, Dunbar C, Goodman S, Agricola B, Byrne E, Raffeld M, Moen R, Bacher J, Zsebo K, Neinhuis A: Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992;176: 1125.
5. Dranoff G, Jaffee EM, Lazenby AJ, Golumbek P, Levitsky HI, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC: Vaccination with irradiated tumor cells engineered to secrete murine GM-CSF stimulates potent, specific, and long lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993;90:3539.
6. Durig J, de Wynter EA, Kasper C, Cross MA, Chang J, Testa NG, Heyworth CM: Expression of macrophage inflammatory protein-1 receptors in human CD34(+)hcmatopoietic cells and their modulation by tumor necrosis factor-alpha and interferon-gamma. Blood 1998;92: 3073-3081.
7. Fujii S, Hamada H, Fujimoto K, Shimomura T, Kawakita M: Activated dendritic cells from bone marrow cells of mice receiving cytokine-expressing tumor cells are associated with the enhanced survival of mice bearing syngeneic tumors. Blood 1999;93:4328-4335.
8. Gastl G, Finstad C, Guarini A, Bosl G, Gilboa E, Bander N, Gansbacher B: Retroviral vector-mediated lymphokinc gene transfer into human renal cells. Cancer Res 1992;52:6229.
9. Wright P, Zheng C, Moyana T, Xiang J: Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression. Cancer Gene Ther 1998;5:371-379.
10. Havell E, Fiers W, North R: The antitumor function of tumor necrosis factor (TNF): I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J Exp Med 1988;167:1067.
11. Karp S, Hwu P, Farber A, Restifo N, Friegler M, Mule J, Rosenberg S: In vivo activity of tumor necrosis factor (TNF) mutants: Secretory but not membrane bound TNF mediates the regression of retrovirally transduced murine tumor. J Immunol 1992;149:2076.
12. Matory YL, Chen M, Goedegebuure PS, Williams A, Eberlein TJ: Anti-tumor activity of three mouse mammary cancer cell lines following interferon-γ gene transfection. Surgery 1995;118:251.
13. Matory Y, Chen M, Dorfman D, Williams A, Goedegebuure P, Eberlein T: Immunologic memory is associated with ICAM-1 upregulation and reversed by CD8 depletion following tumor necrosis factor-gene transfected mouse mammary tumor. Surg Forum 1996;XLVII: 457-459.
14. Henninger DD, Panes J, Eppihimer M, Russell J, Gerritsen M, Anderson DC, Granger DN: Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 1997;158:1825-1832.
15. Batten P, Yacoub MH, Rose ML: Effect of human cytokines (IFN-γ, TNF-α, IL-1β, IL4) on porcine endothelial cells: Induction of MHC and adhesion molecules and functional significance of these changes. Immunology 1996;87: 127-133.
16. Burno DK, Fabian DF, Lefor AT: ICAM-1 increases in vitro adhesion and cytoxicity in a murine fibrosarcoma. J Surg Res 1996;60:398-402.
17. Winterrowd G, Krzeski R, Fleming W, Hatfield C, Sanders M, Chin J: T lymphocyte adhesion to human synovial fibroblasts: Role of cytokines and the interaction between intercellular adhesion molecule 1 and CD11a/CD18. Arthritis Rheum 1991;34:1245.
18. Tessier P, Audette M, Cattaruzzi P, McColl S: Up-regulation by tumor necrosis factor α of intercellular adhesion molecule 1 expression and function in synovial fibroblasts and its inhibition by glucocorticoids. Arthritis Rheum 1993;11:1528.
19. Lauri D, Needham L, Martin-Padura I, Dejana E: Tumor cell adhesion to endothelial cells: Endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor for colon carcinoma cells. J Natl Cancer Inst 1991;83:1321.
20. Rockwell S: In vivo-in vitro tumor systems: New models for studying the response of tumor to therapy. Lab Anim Sci 1977;27:831.
21. Rockwell S: Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro. Br J Cancer 1978:37(suppl III):212.
22. Cailleau R, Young R, Olive M, Reeves W: MB-231 arose from a metastatic pleural effusion in a patient with breast cancer and grows in nude mice. J Natl Cancer Inst 1974;53:661.
23. Lasfrangues E, Coutinho WG, Redfield S: Isolations of two human epithelial cell lines from solid breast carcinomas. J Natl Cancer Inst 1978;61:967.
24. Li L, Price J, Fan D, Zhang R, Bucana C, Fidler I: Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. J Natl Cancer Inst 1989;81:1406-1412.
25. Wang A, Crcasey A, Ladner L, Strickler J, Van Arsdell J, Yamamoto R, Mark D: Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 1985;228:149.
26. Schoof D, Selleck C, Massaro A, Jung S, Eberlein T: Activation of human tumor-infiltrating lymphocytes by monoclonal antibodies directed to the CD3 complex. Cancer Res 1990; 50:1138.
27. Sheehan C, Hrapchak B: Theory and Practice of Histochemistry. Mosby, St. Louis, 1988.
28. Baskar S, Azarenko V, Marshall E, Hughes E, Rosenberg S: MHC class II-transfected tumor cells induce long-term tumor specific immunity in autologous mice. Cell Immunol 1994;155: 123.
29. Ma J, Wang J, Guo Y, Sy M, Bigby M: In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell Immunol 1994; 158:389.
30. Pericle F, Giovarelli M, Colombo M, Ferrari G, Musiani P, Modesti A, Cavallo F, Di Pierro F, Novelli F, Forni G: An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinonia engineered to release IL4. J Immunol 1994;153:5559.
31. Scheynius A, Camp R, Pure E: Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J Immunol 1993;150:655.
32. Rosato A, Zambon A, Macino B, Mandruzzato S, Bronte V, Milan G, Zanovello P, Collavo D: Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area. Int J Cancer 1996;65:847-851.
33. Baskar S, Azarenko V, Marshall EG, Hughes E, Ostrand-Rosenbcrg S: MHC class II-transfected tumor cells induce long-term tumor-specific immunity in autologous mice. Cell Immunol 1994;155:123-133.
34. Hollander M, Wolfe DA: Nonparametric Statistical Methods. New York, Wiley, 1973, p 67.
35. Cavallo F, Di Pierro F, Giovarelli M, Guilino A, Vacca A, Stoppacciaro A, Forni M, Modesti A, Forni G: Protective and curative potential of vaccination with interleukin-2-gene transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Res 1993;53: 5067-5070.
36. Stoppacciaro A, Melani C, Parenza M, Mastracchio A, Bassi C, Baroni C, Parmiani G, Colombo M: Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon-γ. J Exp Med 1993;178:151-161.
37. Matory YL, Chen M, Dorfman DM, Williams A, Goedegebuure PS, Eberlein TJ: Immunologic memory is associated with ICAM-1 upregulation and reversed by CD8 depletion following tumor necrosis factor-α gene-transfected mouse mammary tumor. Abstr Soc Surg Oncol 1996, p. 457.
38. Havell E, Fiers W, North RJ: The antitumor function of tumor necrosis factor (TNF): I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J Exp Med 1988;167:1067.
39. Hawkyard S, Jackson A, Prescott S, James K, Chisholm G: The effect of recombinant cytokines on bladder cancer cells in vitro. J Urol 1993;150:514.
40. Kemeny N, Childs B, Larchian W, Rosado K, Kelsen D: A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma. Cancer 1990;66: 659.
41. Matory YL, Chen M, Dorfman DM, Goedegebuure PS, Williams A, Eberlein TJ: Anti-tumor activity of three mouse mammary cancer cell lines following interferon-γ gene transfection (abstract). Soc Univ Surg 1994;25:25.
42. Malory YL, Chen M, Goedegebuure PS, Eberlein TJ: Anti-tumor activity of three mouse mammary cancer cell lines following cytokine gene transfection. Abstr Soc Surg Oncol 1994, p A8.
43. Pogrebniak H, Witt C, Terrill R, Kranda K, Travis W, Rosenberg S, Pass H: Isolated lung perfusion with tumor necrosis factor: A swine model in preparation of human trials. Ann Thorac Surg 1994;57:1477.
44. Rath U, Kaufmann M, Schmid H, Hofmann J, Wiedenmann B, Kist A, Kempeni J, Schlick E, Bastert G, Kommerell B, Manuel D: Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascites. Eur J Cancer 1991;27:121.
45. Van Morselaar R, Beniers A, Hendricks B, Van der Meide PH, Schellekens H, Debruyne F, Schalken J: In vivo antiproliferative effects of gamma-interferon and tumor necrosis factor alpha in a rat renal cell carcinoma model system. J Urol 1990;143:1247.
46. Weksler B, Blumberg D, Lenert J, Ng B, Fong Y, Burt M: Isolated single-lung perfusion with TNF-α in a rat sarcoma lung metastases model. Ann Thorac Surg 1994;58:328.
47. Wu S, Rodabaugh K, Martinez-Maza O, Watson J, Silberstein D, Boyer C, Peters W, Weinberg J, Berck J, Bast R: Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α. Am J Obstet Gynecol 1992;166:997.